London: The protection offered by the Oxford-AstraZeneca Covid-19 vaccine, named Covishield in India, declines after three months of receiving two doses, according to a study published in the journal The Lancet. The findings suggest that booster programmes are needed to help maintain protection from severe disease, said a team of researchers led by University of […]
The results of a study conducted by ICMR showed that the people in the mix and match group had superior immunogenicity profiles against Alpha, Beta and Delta variants of Covid-19
Following the revision of travel restrictions issued by the Dubai govt which allows fully vaccinated travellers to return to the UAE, Emirates Airlines said it will resume flights from India, South Africa and Nigeria
Passengers arriving in Saudi Arabia must submit a vaccination certificate showing they have received the approved shot, according to guidelines issued by the General Authority of Civil Aviation
The Oxford-AstraZeneca doses from COVAX will be for the most vulnerable persons above 60 years of age group in the most high-risk areas impacted by COVID-19.
As indirect evidence is compatible with protection against severe Covid-19, the situation remains to be demonstrated in ongoing clinical trials and post-implementation evaluations.
AstraZeneca said it had not been able to properly ascertain the effect of the vaccine on severe disease and hospitalisation caused by the South African variant.
